{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:05:36Z","timestamp":1770818736919,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":6094,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.exphem.2005.06.034","type":"journal-article","created":{"date-parts":[[2005,10,11]],"date-time":"2005-10-11T07:23:11Z","timestamp":1129015391000},"page":"1172-1181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T-cell responses as observed in an animal model for human leukemia"],"prefix":"10.1016","volume":"33","author":[{"given":"Bart A.","family":"Nijmeijer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianke L.J.","family":"van Schie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry","family":"Verzaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roel","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H. Frederik","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2005.06.034_bib1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/cncr.11664","article-title":"The biology and therapy of adult acute lymphoblastic leukemia","volume":"98","author":"Faderl","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2005.06.034_bib2","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2005.06.034_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2005.06.034_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/bbmt.1999.v5.pm10465105","article-title":"Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions","volume":"5","author":"Porter","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2005.06.034_bib5","first-page":"1553","article-title":"Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes","volume":"23","author":"Slavin","year":"1995","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2005.06.034_bib6","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","article-title":"Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation","volume":"87","author":"Slavin","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2005.06.034_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bmt.1702555","article-title":"Donor leukocyte infusions in acute lymphocytic leukemia","volume":"26","author":"Collins","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2005.06.034_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(87)90763-X","article-title":"Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias","volume":"2","author":"Maraninchi","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2005.06.034_bib9","first-page":"53","article-title":"Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse","volume":"1","author":"Apperley","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2005.06.034_bib10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","article-title":"Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation","volume":"304","author":"Weiden","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2005.06.034_bib11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2005.06.034_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2005.06.034_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0198-8859(96)00285-6","article-title":"Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells","volume":"53","author":"Smit","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/j.exphem.2005.06.034_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<215::AID-GCC1>3.0.CO;2-5","article-title":"Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response","volume":"20","author":"Eibl","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2005.06.034_bib15","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1073\/pnas.0530192100","article-title":"Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia","volume":"100","author":"Marijt","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2005.06.034_bib16","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.95.17.10152","article-title":"T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation","volume":"95","author":"Smit","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2005.06.034_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V88.1.41.41","article-title":"Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen","volume":"88","author":"Cardoso","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2005.06.034_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-065X.1997.tb00983.x","article-title":"Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts","volume":"157","author":"O'Reilly","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.exphem.2005.06.034_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0301-472X(00)00669-X","article-title":"Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD\/SCID mice","volume":"29","author":"Nijmeijer","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2005.06.034_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1182\/blood.V100.2.654","article-title":"An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD\/scid mice","volume":"100","author":"Nijmeijer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2005.06.034_bib21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.176.5.1283","article-title":"Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia","volume":"176","author":"Faber","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2005.06.034_bib22","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1182\/blood.V91.6.2197","article-title":"Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution","volume":"91","author":"Warren","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2005.06.034_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4049\/jimmunol.158.2.560","article-title":"Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL","volume":"158","author":"Dolstra","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2005.06.034_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.bmt.1703027","article-title":"The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation","volume":"27","author":"Russell","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2005.06.034_bib25","first-page":"1168","article-title":"Expression of costimulatory molecules in human leukemias","volume":"10","author":"Hirano","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2005.06.034_bib26","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/sj.leu.2402273","article-title":"An optimised biphasic culture system for the generation of functional dendritic cells from patients with acute lymphoblastic leukaemia at presentation and in clinical remission","volume":"15","author":"Blair","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2005.06.034_bib27","first-page":"763","article-title":"The in-vitro generation of dendritic cells from blast cells in acute leukaemia","volume":"103","author":"Robinson","year":"1998","journal-title":"Br J Haematol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X05003577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X05003577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:20:14Z","timestamp":1759566014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X05003577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0301472X05003577"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2005.06.034","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T-cell responses as observed in an animal model for human leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2005.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}